Loading...
Guest User
Welcome! Please login.
| IPO Listing At | NSE SME |
| SME IPO Issue Type | Fixed Price Issue |
| Total Issue Size | ₹9.11 Cr |
| Reserved for Market Maker | ₹0.00 Cr |
| Net Issue Size | ₹9.11 Cr |
| Fresh Issue | ₹8.66 Cr |
| Face Value | ₹10 Per Equity Share |
| Issue Price | ₹84.00 per share |
| Discount | Retail: 0.00 |
| NSE Code | SAROJA |
| Registrar | Kfin Technologies Ltd. |
| Lead Managers | Swastika Investmart Ltd. |
Disclaimer: GMP is sourced from grey market dealers and is indicative only. Always conduct your own due diligence.
* Allotment, Refund, Demat Credit & Listing dates are tentative and subject to change.
Minimum bid: 1,600 shares and in multiples thereof
Incorporated in 2019, Saroja Pharma Industries India Limited is engaged in trading, exporting and supplying Specialty Chemicals & API.
The company deals in three types of product categories:
1. Chemical, 2. Pharma Intermediary and 3. Veterinary Pharma API. The company supplies products such as Liquide Bromine, which is used as an agro-intermediate, Ethyl Acetate, which is used as an API solvent, and other pharmaceuticals used for human and veterinary drugs, and some of them are API solvents.
APIs, known as bulk drugs or bulk actives, are the principal ingredients used in making finished dosages in the form of capsules, tablets, liquid or other forms of dosage, with the addition of other APIs or inactive ingredients.
The company exports products mainly in Pakistan, Egypt, Russia, Jordan, Hong Kong, Singapore etc.
Competitive Strength:
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | To Set-up a Manufacturing Unit | 7.05 |
| 2 | To Repay the Unsecured Loans | 1.75 |
| Period Ended | 31 Mar 2023 | 31 Mar 2022 | 31 Mar 2021 |
|---|---|---|---|
| Assets | 21.34 | 15.51 | 8.22 |
| Total Income | 50.35 | 55.96 | 36.75 |
| Profit After Tax | 1.06 | 1.14 | 0.73 |
| NET Worth | 5.09 | 4.03 | 0.94 |
| Reserves and Surplus | 2.15 | 3.80 | 0.93 |
| Total Borrowing | 10.19 | 6.14 | 3.02 |
| Amount in ₹ Crore | |||
| KPI | Mar 31, 2023 |
|---|---|
| ROE | 15% |
| ROCE | 25% |
| Debt / Equity | 2.00% |
| RoNW | 20.85% |
| PAT Margin | 2.11% |
| EBITDA Margin | 5.73% |
| Price to Book Value | 4.85 |
| Metric | Pre IPO | Post IPO |
|---|---|---|
| EPS (₹) | 3.61 | 2.64 |
| P/E (x) | 23.25 | 31.84 |
| Promoter Holding | 100.00% | 73.02% |
| Market Cap | ₹33.77 Cr. | |
